🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the efficacy and safety of ombitasvir/paritaprevir/rit...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-30
Trial ID
NCT02487199
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of a booster...
Status
Enrolling By Invitation
Location
Cantonal Hospital Aarau
Start Date
2023-11-13
Trial ID
NCT06037564
Treatments Being Tested
The purpose of this study is to determine whether atazanavir powder combine...
Status
Completed
Location
Local Institution
Start Date
2010-10-13
Trial ID
NCT01099579
Treatments Being Tested
The purpose of this study is to assess the effectiveness and safety of an a...
Status
Completed
Location
AlabamaTherapeutics CRS
Start Date
2009-04
Trial ID
NCT00830804
Treatments Being Tested
The purpose of this study is to compare the proportion of subjects with HIV...
Status
Completed
Location
Local Institution
Start Date
2005-11
Trial ID
NCT00207142
Treatments Being Tested
This is a double-blind Phase 2a study to test the safety and efficacy of an...
Status
Terminated
Location
Research Site
Start Date
2012-12
Trial ID
NCT01737359
Treatments Being Tested
The purpose of this study is to determine the safety and effectiveness of a...
Status
Completed
Location
University of Colorado Health Sciences Center
Start Date
2007-01
Trial ID
NCT00414518
Treatments Being Tested
The purpose of this study is to evaluate the antiviral activity as measured...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00838162
The AGILE platform master protocol allows incorporation of a range of ident...
Status
Recruiting
Location
Desmond Tutu Health Foundation
Start Date
2020-07-03
Trial ID
NCT04746183
Atazanavir (ATV) and fosamprenavir (fAPV) are new protease inhibitors that ...
Status
Completed
Location
Thomas Street Health Center
Start Date
2004-05
Trial ID
NCT00242216
Treatments Being Tested